ArticleJournal of experimental & clinical cancer research : CR2022

Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction.

Pei Jye Voon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.